Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-09-04

Clinical Trial Update: Efficacy, Safety and Tolerability of Rotigotine Nasal Spray for the Acute Treatment of RLS Symptoms [Phase 2]

View source ↗

Summary

Phase 2 trial update of rotigotine nasal spray for acute treatment of Restless Legs Syndrome reports efficacy, safety and tolerability findings.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rotigotine nasal spray (rotigotine)

Snippet

Sponsor: UCB Pharma | Conditions: Restless Legs Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2009-09-04